A patient decision aid for systemic lupus erythematosus improves shared decision-making and patient-provider communication in ...

A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

Notably, 2 deaths occurred in the iscalimab group, 1 due to urosepsis and another associated with macrophage-activation syndrome. Opportunistic infections, including tuberculosis and herpes zoster, ...

The latest spate of wolf attacks in Majhara Tokli alone has claimed six lives, mostly children, and left over two dozen injured in just a month.

Wolves are returning to Europe, prompting both fear and delight. In forests west of Stockholm, Kate Maxwell and her daughter ...

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients1-3 Fabhalta is first and only approved complement inhibitor for adults ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

After Barbara Palvin underwent surgery for endometriosis, she revealed how life has been since been "like day and night" in ...

Sjögren’s disease incidence is greater in Alaska Native and American Indian populations in Alaska than in the general ...

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...